Iovance Biotherapeutics, Inc.

United States of America


 
Total IP 332
Total IP Rank # 3,872
IP Activity Score 3.3/5.0    354
IP Activity Rank # 2,027
Stock Symbol
ISIN US4622601007
Market Cap. 2,800M  (USD)
Industry Biotechnology
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

171 18
48 11
75 5
4
 
Last Patent 2025 - Processes for production of tumo...
First Patent 2017 - Programmed death 1 ligand 1 (pd-...
Last Trademark 2025 - IOVANCECARES
First Trademark 2017 - IOVANCE

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 G/S Pharmaceuticals for the treatment of oncological disease and disorders, cancer and tumors; pharma...
G/S Telecommunications services, namely, transmission of voice, audio, data, graphics, and video betw...
G/S Pharmaceutical preparations and biological preparations for the treatment of immune system relate...
2024 Invention Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy. Th...
Invention Treatment with tumor infiltrating lymphocyte therapies in combination with ctla-4 and pd-1 inhibi...
Invention Methods of gene-editing using programmable nucleases. Some embodiments disclosed herein provide a...
Invention Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with tro...
Invention Cytokine encoding lentiviral vectors and uses thereof for making tumor infiltrating lymphocytes. ...
Invention Processes for generating til products enriched for tumor antigen-specific t-cells. The present i...
Invention Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof. Met...
Invention Treatment of nsclc patients with tumor infiltrating lymphocyte therapies. The present invention ...
Invention Treatment of nsclc patients refractory for anti-pd-1 antibody. The present invention provides im...
Invention Methods and compositions for t-cell coculture potency assays and use with cell therapy products. ...
Invention Til expansion processes using specific cytokine combinations and/or akti treatment. Provided her...
Invention Til expansion from fine needle aspirates and small biopsies. The present disclosure provides met...
Invention Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy. ...
Invention Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy....
Invention Use of til as maintenance therapy for nsclc patients who achieved pr/cr after prior therapy. The ...
2023 Invention Processes for production of tumor infiltrating lymphocytes with shortened rep step. The present i...
Invention Methods for assessing proliferation potency of gene-edited t cells. The present invention provide...
Invention Two-dimensional processes for the expansion of tumor infiltrating lymphocytes and therapies there...
Invention Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof. Meth...
Invention Methods for tumor infiltrating lymphocyte (til) expansion related to cd39/cd103 selection. Provid...
G/S pharmaceuticals for the treatment of oncological disease and disorders, cancer and tumors; pharma...
Invention Processes for generating til products using pd-1/tigit talen double knockdown. The present invent...
Invention Devices and processes for automated production of tumor infiltrating lymphocytes. A cell culture ...
Invention Packaging for biological samples
Invention Packaging for biological samples. A packaging and transporting device for a biological sample inc...
Invention Tumor infiltrating lymphocytes engineered to express payloads. A method of expanding tumor infil...
Invention Cytokine associated tumor infiltrating lymphocytes compositions and methods. Provided herein are...
Invention Tissue fragmenter and methods of using the same. A tissue fragmenting device and methods of usin...
2022 Invention Methods of expansion treatment utilizing cd8 tumor infiltrating lymphocytes. Provided herein are...
G/S Pharmaceuticals for the treatment of oncological disease and disorders, cancer and tumors; pharm...
Invention Processes for generating til products using pd-1 talen knockdown. The present invention provides...
Invention Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with kra...
Invention Method for cryopreservation of solid tumor fragments. The present invention provides improved me...
Invention Pd-1 gene-edited tumor infiltrating lymphocytes and uses of same in immunotherapy. Provided here...
Invention Chimeric costimulatory receptors, chemokine receptors, and the use of same in cellular immunother...
Invention Methods for infiltrating lymphocyte (til) expansion related to cd39/cd69 selection and gene knock...
Invention Adjuvant therapy for cancer. The present invention provides methods for expanding TILs and produ...
2021 Invention Devices and processes for automated production of tumor infiltrating lymphocytes. The present in...
Invention Treatment of cancers with tumor infiltrating lymphocyte therapies. Provided herein are methods f...
Invention Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with bra...
G/S Telecommunications services, namely, transmission of voice messages, audio clips, medical records...
G/S Telecommunications services, namely, transmission of voice, audio, data, graphics, and video bet...
2020 G/S telecommunications services, namely, transmission of data and graphics between healthcare provide...
G/S Pharmaceutical preparations and biological preparations for the treatment of immune system relat...
G/S biological preparations for the treatment of immune system related and oncological diseases and d...
2018 G/S Downloadable application for mobile phones for scheduling and tracking medical patient appointmen...
G/S Providing downloadable mobile applications for scheduling and tracking medical patient appointme...
G/S downloadable mobile applications for scheduling and tracking medical patient appointments, medica...
2017 G/S Cells for cancer treatment research; cell therapy preparations for use in clinical research; biol...
G/S Cells for cancer treatment research; chemical preparations for use in clinical research; biologic...
G/S cells for cancer treatment research; chemical preparations for use in clinical research; biologic...